Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D Ryder

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Alimentary Pharmacology & Therapeutics|December 19, 2019
Commentary: elastography as a predictor of portal hypertensionStephen D Ryder
Clinical Medicine (London, England)|April 1, 2015
Chronic hepatitis C - what do the new drugs offer and who should get them first?Stephen D Ryder
Journal of Hepatology|May 22, 2007
Outcome of hepatitis C infection: bleak or benign?Stephen D Ryder
European Journal of Gastroenterology & Hepatology|March 16, 2006
Progression of hepatic fibrosis in chronic hepatitis C and the need for treatment in mild diseaseAdam Lawson, Stephen D Ryder
Current Opinion in Infectious Diseases|November 3, 2015
The hepatitis C revolution part 1: antiviral treatment optionsPrarthana Thiagarajan, Stephen D Ryder
Journal of Hepatocellular Carcinoma|May 30, 2017
Screening for hepatocellular carcinoma: patient selection and perspectivesWaleed Fateen, Stephen D Ryder
Current Opinion in Infectious Diseases|November 3, 2015
The hepatitis C revolution part 2: difficult-to-treat groups and experimental approachesPrarthana Thiagarajan, Stephen D Ryder
BMJ (Clinical Research Ed.)|September 2, 2006
Biochemical "liver function tests"W Stuart A Smellie, Stephen D Ryder
BMJ (Clinical Research Ed.)|February 22, 2003
Epistaxis: an overlooked cause of massive haematemesis in cirrhosisShawinder S Johal, Andrew S Austin, Stephen D Ryder
Drug and Alcohol Review|May 31, 2022
Alcohol-related liver disease mortality and missed opportunities in secondary care: A United Kingdom retrospective observational studyMohsan Subhani, Rebecca Elleray, Jane Bethea, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Alimentary Pharmacology & Therapeutics|December 19, 2019
Commentary: elastography as a predictor of portal hypertensionStephen D Ryder
Clinical Medicine (London, England)|April 1, 2015
Chronic hepatitis C - what do the new drugs offer and who should get them first?Stephen D Ryder
Journal of Hepatology|May 22, 2007
Outcome of hepatitis C infection: bleak or benign?Stephen D Ryder
European Journal of Gastroenterology & Hepatology|March 16, 2006
Progression of hepatic fibrosis in chronic hepatitis C and the need for treatment in mild diseaseAdam Lawson, Stephen D Ryder
Current Opinion in Infectious Diseases|November 3, 2015
The hepatitis C revolution part 1: antiviral treatment optionsPrarthana Thiagarajan, Stephen D Ryder
Journal of Hepatocellular Carcinoma|May 30, 2017
Screening for hepatocellular carcinoma: patient selection and perspectivesWaleed Fateen, Stephen D Ryder
Current Opinion in Infectious Diseases|November 3, 2015
The hepatitis C revolution part 2: difficult-to-treat groups and experimental approachesPrarthana Thiagarajan, Stephen D Ryder
BMJ (Clinical Research Ed.)|September 2, 2006
Biochemical "liver function tests"W Stuart A Smellie, Stephen D Ryder
BMJ (Clinical Research Ed.)|February 22, 2003
Epistaxis: an overlooked cause of massive haematemesis in cirrhosisShawinder S Johal, Andrew S Austin, Stephen D Ryder
Drug and Alcohol Review|May 31, 2022
Alcohol-related liver disease mortality and missed opportunities in secondary care: A United Kingdom retrospective observational studyMohsan Subhani, Rebecca Elleray, Jane Bethea, et al.
Pageof 8